PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Other Assets, Current in USD from Q4 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Provectus Biopharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2014 to Q4 2024.
  • Provectus Biopharmaceuticals, Inc. Other Assets, Current for the quarter ending December 31, 2024 was $236K.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $236K Dec 31, 2024 10-K 2025-03-28
Q2 2017 $245K -$71.6K -22.6% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $251K -$86.4K -25.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $361K +$319K +775% Dec 31, 2016 10-Q 2017-08-09
Q3 2016 $187K -$879K -82.4% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $317K -$869K -73.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $337K -$887K -72.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $41.2K -$937K -95.8% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $1.07M Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $1.19M Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $1.22M Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $978K Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.